Neurology Clinical Pharmacology Flashcards
What is idiopathic parkinson’s disease?
neudegenerative disorder
Progressive clinical course
Motor symptoms improve with levodopa
Non-motor symtoms
What are the clinical features of Parkinsonism?
Tremor - low frequency, pill rolling tremor
Rigidity - lead pipe rigidity
Bradykinesia
Postural instability
What are the non motor manifestations of parkinson’s?
Mood changes Pain - starts asymmetrical Cognitive change Urinary change Urinary symptoms Sleep disorder - REM sleep behaviour disorder Sweating
What is the prognosis of PD after 15 years?
94% dyskinesia 81% falls 84% cognitive decline - 50% hallucinations 80% somnolence 50% swallowing difficulty 27% severe speech problems.
How do you diagnose ID?
Clinical features
Exclude other causes of Parkinsonism
Response to Treatment
Structural neuroimaging is normal
Describe the pathology of IPD?
Neurodegeneration
Lewy bodies - synucleinopathy
Loss of pigment - 50% loss before symptoms, increased turnover, upregulate receptors
Reduced dopamine
What is a DAT scan?
Labelled tracer Presynaptic uptake Abnormal in PD Not diagnostic Tremor Neuroleptic Vascular
Describe the synthesis of catecholamines
L-Tyrosine (tyrosine hydroxylase) L-DOPA (DOPA decarboxylase) Dopamine (Dopamine B-Hydroxylase) Noradrenaline (Phenylethanolamine n-methyltransferse) Adrenaline
Why do we use L-DOPA and not dopamine?
As Dopamine cannot cross BBB
Describe the pharmacokinetics of levodopa
Oral administration
absorbed by AT - in competition with amino acids
90% inactivated in intestinal wall (monoamine oxidase and DOPA decarboxylase)
T1/2 = 2 hours so:
-Short dose internal (4x day)
fluctuations in blood levels and symptoms
9% converted to dopamine in peripheral tissues - DOPA decarboxylase
<1% enters CNS - competes with AA for AT across BBB.
What are the formulations of L-DOPA?
Dopamine is used in combination with a peripheral DOPA decarboxylase inhibitor:
- Co-careldopa = Sinemet
- Co-beneldopa = Madopar
This reduces the dosing required
Reduces side effects
Increases L-DOPA reaching the brain
Tablets only - standard dosage of variable strengths.
What are the advantages of L-DOPA?
Highly efficacious
Low side effects:
Nausea / anorexia - vomiting centres
Hypotension - central and peripheral
Psychosis - schizophrenia like effects - hallucinations / delusions / paranoia
Tachycardia
What are the disadvantages of L-DOPA?
Precursor - needs enzyme conversion
Long term - loss of efficacy Involuntary movements Motor complications: On/Off Wearing off - need before next dose Dyskinesias Dystonia Freezing
What are the interactions with L-DOPA?
B6 increases peripheral breakdown of L-DOPA
MAOIs risk hypertensive crisis
Many antipsychoticdrigs block dopamine receptors and parkinsonism is a side effect
What are dopamine receptor agonists?
A do novo, add on therapy.
e.g. Ropinirole, pramipexole (tablet), apomorphine (subcut, only for patients with severe motor fluctuations)